Schultz Exits: Pressures From Inside And Out Catch Up With CDRH Director
This article was originally published in The Gray Sheet
Executive Summary
At least a handful of disgruntled employees, members of Congress champing at the bit and a new reformist FDA administration were apparently the undoing of Dan Schultz's leadership of CDRH